These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1626 related items for PubMed ID: 19111490

  • 1. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F, Yaylali GF, Turgut S, Kaptanoglu B.
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM, Khalid BA.
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [Abstract] [Full Text] [Related]

  • 3. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [Abstract] [Full Text] [Related]

  • 4. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T, Takanashi K, Takebayashi K, Fujiwara Y, Tayama K, Takemura Y.
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
    Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P, Epaminonda P, Arosio M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF, Bonati ME, Stucci N.
    Diabetes Res; 1994 Dec; 27(1):15-25. PubMed ID: 7648793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM, Sun XJ, Shao P.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2077-82. PubMed ID: 19080279
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
    Zimmermann-Belsing T, Juul A, Juul Holst J, Feldt-Rasmussen U.
    Growth Horm IGF Res; 2004 Jun 20; 14(3):235-44. PubMed ID: 15125885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr 20; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 16. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Apr 20; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

  • 17. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.
    Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R.
    J Clin Endocrinol Metab; 1993 Apr 20; 76(4):950-5. PubMed ID: 7682563
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG.
    Endocrinology; 1993 Feb 20; 132(2):781-8. PubMed ID: 7678799
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.
    Scand J Clin Lab Invest; 2007 Feb 20; 67(5):553-9. PubMed ID: 17763192
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 20; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.